Quickly Spot Consensus Among the World's Best Equity Analysts
| Name | Upside % |
Analysts bullish % |
|
|---|---|---|---|
|
302%
upside
3 price targets
|
0
%
|
|
|
|
289%
upside
3 price targets
|
0
%
|
|
|
|
283%
upside
4 price targets
|
0
%
|
|
|
29
Sagimet Biosciences
SGMT
$245M
|
277%
upside
3 price targets
|
0
%
|
|
|
263%
upside
4 price targets
|
0
%
|
|
|
|
247%
upside
3 price targets
|
0
%
|
|
|
|
236%
upside
3 price targets
|
0
%
|
|
|
|
225%
upside
4 price targets
|
0
%
|
|
|
|
218%
upside
3 price targets
|
0
%
|
|
|
|
214%
upside
4 price targets
|
0
%
|
|
|
36
Atai Beckley NV
ATAI
$1.58B
|
213%
upside
3 price targets
|
0
%
|
|
|
212%
upside
3 price targets
|
0
%
|
|
|
|
211%
upside
4 price targets
|
0
%
|
|
|
|
210%
upside
5 price targets
|
0
%
|
|
|
|
206%
upside
4 price targets
|
0
%
|
|
|
|
205%
upside
5 price targets
|
0
%
|
|
|
|
203%
upside
4 price targets
|
0
%
|
|
|
|
202%
upside
3 price targets
|
0
%
|
|
|
|
197%
upside
5 price targets
|
0
%
|
|
|
|
197%
upside
4 price targets
|
0
%
|
|
|
|
195%
upside
3 price targets
|
0
%
|
|
|
|
194%
upside
3 price targets
|
0
%
|
|
|
|
187%
upside
5 price targets
|
0
%
|
|
|
|
187%
upside
7 price targets
|
0
%
|
|
|
|
186%
upside
4 price targets
|
0
%
|
|